Insider Transactions in Q4 2025 at Beta Bionics, Inc. (BBNX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2025
|
Sean Saint President & CEO |
SELL
Open market or private sale
|
Direct |
3,278
-3.24%
|
$95,062
$29.34 P/Share
|
|
Dec 02
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,427
-3.24%
|
$41,383
$29.34 P/Share
|
|
Dec 02
2025
|
Mike Mensinger Chief Product Officer |
SELL
Open market or private sale
|
Direct |
1,063
-1.16%
|
$30,827
$29.34 P/Share
|
|
Dec 01
2025
|
Maria Palasis |
SELL
Open market or private sale
|
Direct |
1,406
-7.4%
|
$40,774
$29.65 P/Share
|
|
Dec 01
2025
|
Adam Lezack |
SELL
Open market or private sale
|
Direct |
1,406
-7.4%
|
$40,774
$29.63 P/Share
|
|
Oct 31
2025
|
Maria Palasis |
SELL
Open market or private sale
|
Direct |
1,406
-6.32%
|
$37,962
$27.16 P/Share
|
|
Oct 31
2025
|
Adam Lezack |
SELL
Open market or private sale
|
Direct |
1,406
-6.27%
|
$37,962
$27.28 P/Share
|
|
Oct 03
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,982
-5.18%
|
$104,622
$21.9 P/Share
|
|
Oct 03
2025
|
Stephen Feider Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,982
+9.23%
|
$24,910
$5.1 P/Share
|
|
Oct 01
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,018
-12.74%
|
$300,360
$20.92 P/Share
|
|
Oct 01
2025
|
Stephen Feider Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,018
+20.27%
|
$75,090
$5.1 P/Share
|